Op magnetische kralen gebaseerde nucleïnezuurextractietechnologie: Leading the efficiency revolution in the biopharmaceutical industry

In the current era of surging demands for precision medicine and large-scale disease screening, a key technology is quietly driving the efficiency revolution in the biopharmaceutical industry – magnetische parelgebaseerde nucleïnezuurextractie. With its significant advantages of high efficiency, automatisering, en hoge zuiverheid, this technology has rapidly become an indispensable core tool in molecular diagnostics, gensequencing, and new drug development fields.

Met behulp van onze serum-/plasmavirusnucleïnezuurextractiereagentia, HBV nationale standaard gradiëntverdunningsmiddelen werden geëxtraheerd op het automatische nucleïnezuurextractie- en zuiveringsinstrument LJbio32H. De geëxtraheerde producten van elk concentratiegradiëntverdunningsmiddel werden gedetecteerd met HBV-qPCR, met een correlatiecoëfficiënt R>0.99. De specifieke gegevens zijn als volgt:

Resultaatanalyse：De nauwkeurigheid van het reagens is zeer hoog, en de gevoeligheid is nog steeds goed bij het extraheren van monsters met lage concentraties.

Compared with the traditional centrifugal column method, magnetic bead-based extraction achieves rapid separation and purification through the specific binding of nucleic acids to surface-modified magnetic particles under the action of an external magnetic field. This principle enables breakthroughs in throughput, snelheid, and consistency. De afgelopen jaren, this technology has excelled in scenarios such as large-scale screening of infectious diseases (such as COVID-19 nucleic acid testing), vloeibare tumorbiopsie (microscopic ctDNA capture), and genetic disease analysis, effectively supporting high-throughput, standardized modern testing requirements.

Nucleic acids were extracted from trace amounts of human Hela cells as samples, 5 cellen, 10 cellen, 20 cellen, 500 cells were extracted, and the nucleic acids obtained were analyzed using Agilent 4200 Nucleic acid fragment distribution, and the results obtained are shown below: 

1. The Electropherogram of Agilent 4200 High Sensitivity RNA ScreenTape Assay

D1: 50 Hela cellsG1: 20 Hela cellsB2: 10 Hela cellsE2: 5 Hela cells

2. Peak diagram of the 50/20/10/5 Hela cells extracted

• Peak diagram of the 5 Hela cells extracted

• . Qubit’s test results

Nee.	Monster intake	Opbrengst（ng/μl）
1	50 Hela cells	0.242
2	20 Hela cells	0.136
3	10 Hela cells	0.112
4	5 Hela cells	0.096

Resultaatanalyse： By Agilent 4200 electrophoresis results can be seen: 5– 50 traces of human Hela cell samples, can be obtained by the nucleic acid fragments, The extraction products were 18s RNA, 28sRNA, and DNA over 800bp.

The wave of industry innovation continues to surge. Domestic leading enterprises have launched fully automated solutions integrating magnetic bead extraction, bereiken “sample input and result output” in closed tubes, reducing extraction time to minutes and significantly enhancing emergency testing capabilities. Tegelijkertijd, breakthroughs in domestic high-end magnetic bead raw materials, such as those from companies like Shanghai Lingjun Biotechnology, have broken the import monopoly, reducing the cost of a single sample by over 30%, significantly enhancing the autonomy of the industrial chain. Capital markets have shown great favor for this sector, with many related enterprises completing large-scale financing recently, driving technological iteration into a fast lane.

Kijkend naar de toekomst, with the explosion of personalized medical care and immediate testing (POCT) demands, magnetic bead-based technology is evolving towards higher sensitivity, better anti-interference performance, and green biodegradability. Its combination with microfluidics and artificial intelligence is expected to give rise to a new generation of intelligent extraction platforms, continuously providing key infrastructure for the innovation and development of the biopharmaceutical industry.

Leverancier

Shanghai Lingjun Biotechnologie Co., Ltd.werd opgericht in 2016 dat een professionele fabrikant is van biomagnetische materialen en reagentia voor nucleïnezuurextractie.

We hebben een rijke ervaring in de extractie en zuivering van nucleïnezuren, eiwit zuivering, cel scheiding, chemiluminescentie, en andere technische gebieden.

Onze producten worden op veel gebieden veel gebruikt, zoals medische testen, genetische testen, universitair onderzoek, genetische veredeling, enzovoort. Wij leveren niet alleen producten, maar kunnen ook OEM ondernemen, ODM, en andere behoeften. Als u een gerelateerde behoefte heeft, Neem gerust contact met ons op .